Intensive care unit (ICU) patients who received haloperidol (Haldol) for delirium fared no better on the AID-ICU trial's primary outcome at 3 months than those who received placebo. At 90 days, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results